Zhimin Shao, Professor
Fudan University · Fudan U
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Zhimin Shao, Professor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:18 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05860907 · Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral MetastasisFudan University · not yet recruiting · Breast Cancer Stage IV · principal investigator
- Ph2NCT05582499 · Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant TherapyFudan University · recruiting · Breast Neoplasm, Breast Cancer, Breast Tumors · principal investigator
- Ph2NCT05303038 · Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline TherapyFudan University · unknown · Metastatic Breast Cancer in the Liver · principal investigator
- Ph2NCT05076682 · Reverse Triple Negative Immune Resistant Breast CancerFudan University · recruiting · Triple-negative Breast Cancer · principal investigator
- Ph3NCT04629846 · Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.Qilu Pharmaceutical Co., Ltd. · completed · Breast Cancer · principal investigator
- Ph3NCT04296175 · Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)Fudan University · active not recruiting · Triple-negative Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.